.avif)
UroVysion FISH Test - Bladder Cancer Biomarker
UroVysion FISH is a non‑invasive urine molecular test that detects chromosomal abnormalities associated with bladder (urothelial) cancer to screen for disease and monitor for recurrence. Detecting cancerous changes earlier enables prompt evaluation and treatment, helping prevent progression to more advanced bladder disease.
BTA Test - Bladder Cancer Biomarker
The BTA (bladder tumor antigen) urine test is a rapid, non‑invasive immunoassay that detects bladder tumor–associated antigen to help screen for or monitor bladder cancer. By aiding earlier detection or surveillance of recurrence, it can help avoid delayed diagnosis and progression to more advanced bladder cancer when used alongside other clinical evaluations.
NMP22 Test - Bladder Cancer Biomarker
The NMP22 urine test detects elevated Nuclear Matrix Protein 22 levels linked to bladder cancer, offering a non‑invasive option for screening and monitoring. By helping spot cancer early or detect recurrence, it can prompt faster diagnosis and treatment, potentially avoiding advanced disease and more invasive therapies.
.svg)
